Global Transplant Diagnostics Market Opportunities And Strategies 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s transplant diagnostics market report forecasts the transplant diagnostics market size to grow to $2.4 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.
Learn More On The Transplant Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Transplant Diagnostics Market Size Forecast
The global transplant diagnostics market is expected to grow from $1.66 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 9.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The transplant diagnostics market is expected to grow from $2.4 billion in 2027 at a CAGR of 7.2%.
North America held the largest transplant diagnostics market share.
Key Transplant Diagnostics Market Driver – Increase In Organ Failure Rates, Thus Increasing The Demand For Transplant Procedures
According to the United Network for Organ Sharing, a US-based non-private organization that manages organ transplantation in the US, in the year 2021, The U.S. saw a record-setting number of organ transplants. 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplantation procedures were performed in 2021. This high demand for diagnostic tests is driving the transplant diagnostics market.
Request for A Sample Of The Global Transplant Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp
Key Transplant Diagnostics Market Trend – Adopting NGS Technology
Companies in the transplant diagnostics market are using Next Generation Sequencing (NGS) for conducting tests to match organ donors and recipients. NGS technology allows the sequencing of an entire human genome, i.e. millions of DNA molecules within a single day. In Next-generation sequencing (NSG), genes are matched between the donor and recipient and depending on the extent of the match, a decision to perform organ transplantation is made. Nearly all transplant diagnostic tests and devices currently use this technology to decide on organ transplantation. For example, Castle Biosciences launched the Decision Dx-CMSeq Test that used NGS (Next Generation Sequencing) to identify somatic mutations in genes.
Transplant Diagnostics Market Segment
1) By Type: Reagent & Consumables, Instrument, Software & Services
2) By Transplant Type: Solid Organ, Stem Cell
3) By End User: Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers
4) By Technology: Non-Molecular Assay, Molecular Assay
5) By Organ: Kidney, Liver, Heart, Lung, Pancreas
Transplant Diagnostics Market Major Players and Strategies
Major players in the transplant diagnostics market are Thermo Fisher ScientificInc., Illumina Inc., F. Hoffmann La-Roche AG., Abbott Laboratories Inc., Qiagen N.V., Immucor Transplant Diagnostics Inc., Bio-rad Laboratories Inc., Omixon Ltd., CareDx, Affymetrix Inc., and GenDx.
In August 2022, Eurobio Scientific, a France-based biotechnology company, acquired GenDx for $134.3 million(€135 million). The acquisition would help Eurobio to expand its research in the areas of transplantation. Genome Dx is a Netherlands-based molecular diagnostics startup.
The Transplant Diagnostics Global Market Report 2023 covers regional data on transplant diagnostics market size, transplant diagnostics market trends and drivers, opportunities, strategies, and transplant diagnostics market competitor analysis. The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Transplant diagnostics are the tests conducted before relocation/ transplantation of the donor organ to the recipient patient. Histocompatibility and immunogenetics are the main topics of transplantation diagnostics in the context of organ transplantation and hematopoietic stem cell transplantation.
View More Reports Related To The Transplant Diagnostics Market –
Diagnostic Imaging Equipment Global Market Report 2023
Microbiology Diagnostic Devices And Equipment Global Market Report 2023
Medical And Diagnostic Laboratory Services Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: